The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

The FDA suggests that prescribed users also reduce their calorie intake and increase their exercise The weight loss drug ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health condition, ...

Popular weight loss drug Zepbound, which is already approved to treat obesity, now becomes the first drug to ever treat sleep ...

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec ... "Zepbound promotes weight loss and has been shown to reduce apnea ...

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the ...

Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.

The FDA first approved Zepbound to treat obesity in ... Medicare does not cover weight-loss drugs specifically for obesity, although the medications can be covered for conditions exacerbated ...

Sally Seymour of the FDA's Center for Drug Evaluation and Research ... a move that would have to be approved by the incoming Trump administration. Rapid weight loss has been a hallmark of ...